Core Points - There is currently no specific medication for Chikungunya fever, and treatment focuses on symptom relief, such as using acetaminophen for fever and joint pain [1][2] - The World Health Organization (WHO) has released health knowledge and prevention measures regarding Chikungunya fever, urging collective efforts to reduce transmission risks [1][5] Group 1: Disease Overview - Chikungunya fever is a viral disease transmitted by mosquito bites, primarily by Aedes aegypti and Aedes albopictus [1] - Symptoms include fever, joint pain, muscle pain, headache, and rash, with most patients recovering within a week, although joint pain may persist longer [1][2] Group 2: Risk Groups - All age groups can be affected, but the elderly, infants, pregnant women, and individuals with pre-existing conditions like hypertension, diabetes, and heart disease are at higher risk for severe symptoms or slower recovery [1][2] Group 3: Treatment and Diagnosis - There is no specific treatment for Chikungunya; management focuses on symptom relief and hydration [1] - Diagnosis requires laboratory testing due to symptom similarities with other diseases like dengue and Zika virus; blood samples can detect the virus within the first week of illness [3] Group 4: Prevention Measures - The best prevention methods include mosquito control and personal protection, such as wearing long clothing and using insect repellent [4] - To reduce mosquito breeding, it is essential to cover, empty, and clean containers that hold water, and to manage waste properly [4] Group 5: Current Situation and Alerts - WHO experts have issued alerts to prepare for potential outbreaks, recalling a significant outbreak in the Indian Ocean region about 20 years ago that affected approximately 500,000 people [5][6] - In 2023, an estimated one-third of the population in Réunion Island, a French territory in the Indian Ocean, has been infected, with cases also reported in Southeast Asia and Europe [5][6]

Core Insights - The demand for mosquito repellent products has surged significantly due to seasonal factors and the impact of recent health concerns, particularly the spread of Chikungunya virus [1][2][4] Group 1: Sales Growth - Sales of mosquito repellent products, such as flower dew and repellent liquids, have seen remarkable increases, with flower dew sales up at least 45% year-on-year and repellent liquid sales doubling [2] - In the Guangdong region, online orders for mosquito repellent products have increased by over 150% in the past week [4] Group 2: Product Information - Flower dew is categorized into "regular" and "mosquito repellent" types, with the latter containing active ingredients like DEET and Picaridin, which provide varying durations of effectiveness [2] - The mosquito repellent flower dew containing DEET is suitable for outdoor use and can last between 2 to 8 hours [2] Group 3: Usage Guidelines - Users are advised to apply flower dew to exposed areas while avoiding sensitive regions and to keep it away from fire sources to prevent ignition [3] - Special precautions are recommended for children, such as avoiding application on hands to prevent ingestion and using it on clothing instead of directly on the skin [3] Group 4: Health Advisory - There is currently no specific antiviral treatment for Chikungunya; management focuses on rest, hydration, and symptomatic relief with over-the-counter medications [1][4] - Increased online consultations regarding Chikungunya prevention and treatment have been noted, indicating a heightened public awareness and concern [4]